Our groups determined several other important structures: together with the late Herman Bujard, we determined the structure of the malaria surface protein MSP1 (Dijkman et al., 2021), which he developed over 40 years into a malaria vaccine candidate currently undergoing clinical trials (Blank et al., 2020). This evidence concerns the gene ATAD1 and malaria.